// App-Quantinova.ai

1300 : CT scan normalization to improve radiomics generalizability and assess progression-free survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A multicentric study

Researchers

Presenter

  • Marion Tonneau

Principal Investigators

  • Cécile Low-Kam

  • Francis Dutil

  • Suzanne Kazandjian

  • Davy Vanderweyen

  • Justin Panasci

  • Julie Malo

  • François Coulombe

  • Arielle Elkrief

  • Wiam Belkaid

  • Lisa Di Jorio

  • Michele Orain

  • Nicole Bouchard

  • Thierry Muanza

  • Kam Kafi

  • Florent Chandelier

  • Philippe Joubert

  • Bertrand Routy

Medical Centers

  • CHUS, Sherbrooke, QC, Canada

  • CRCHUM, Montreal, QC, Canada

  • Jewish General Hospital, Montreal, QC, Canada

  • Imagia Canexia Health, Montreal, Canada

  • IUCPQ, Quebec, QC, Canada

  • Centre Hospitalier de Sherbrooke, Sherbrooke, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final